Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Watson W. Mark, Director. Director active across 3 companies, notably Vaxart, Inc.. In total, 16 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €37k. History available since 19 May 2021. The latest transaction was filed on 17 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
694 shares@ US$41.4350.0% of flowCommon StockSEC:0001127602-21-017319:0
16 of 16 declarations
About Watson W. Mark
Mark Watson is a Director at Vaxart, Inc., SYKES ENTERPRISES INC, and BIODELIVERY SCIENCES INTERNATIONAL INC. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His diverse experience is valuable in guiding these organizations towards their objectives.